Parapneumonic pleural infection/pleural empyema
Conditions
Brief summary
Length of hospital stay (LOS) during the first 30 days.
Detailed description
Measures related to treatment (duration of chest tube drainage, delayed discharge days, re-intervention and re-admission rates, morbidity, mortality, type and duration of antibiotic treatment and pain medication)., Patient reported outcomes (pain, health related quality of life, limitations in daily activities, return to work)., Economic evaluation (healthcare costs, costs of patient, costs of productivity loss, health related quality of life).
Interventions
DRUGActilyse 20 mg
DRUGpoeder en oplosmiddel voor oplossing voor injectie en infusie
DRUGPulmozyme 2500 E/2
DRUG5 ml
DRUGverneveloplossing
Sponsors
Amsterdam UMC Stichting
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Length of hospital stay (LOS) during the first 30 days. | — |
Secondary
| Measure | Time frame |
|---|---|
| Measures related to treatment (duration of chest tube drainage, delayed discharge days, re-intervention and re-admission rates, morbidity, mortality, type and duration of antibiotic treatment and pain medication)., Patient reported outcomes (pain, health related quality of life, limitations in daily activities, return to work)., Economic evaluation (healthcare costs, costs of patient, costs of productivity loss, health related quality of life). | — |
Outcome results
None listed